Citations

Showing 10 of 108162 citations.

Cavitary Coccidioidomycosis: Impact of azole antifungal therapy
Panicker, Renni R, Bartels, Helen Caroline , Ampel, Neil M. , Lim, Elisabeth S. , Blair, Janis E. , Bartels, Helen C, Gotway, Michael B. , Buras, Matthew

Mayo Clinic

Medical Mycology | March 14, 2021 | Volume: 59 | Issue: 8 | Pages: 834-841

10.1093/mmy/myab011 | PMID 33724424 Get It

Abstract Approximately 5 to 15% of patients with pulmonary coccidioidomycosis subsequently develop pulmonary cavities. These cavities may resolve spontaneously over a number of years; however, some cavities never close, and a small proportion causes complications such as hemorrhage, pneumothorax or empyema. The impact of azole antifungal treatment on coccidioidal cavities has not been studied. Because azoles are a common treatment for symptomatic pulmonary coccidioidomycosis, we aimed to assess the impact of azole therapy on cavity closure. From January 1, 2004, through December 31, 2014, we retrospectively identified 313 patients with cavitary coccidioidomycosis and excluded 42 who had the cavity removed surgically, leaving 271 data sets available for study. Of the 271 patients, 221 (81.5%) received azole therapy during 5-year follow-up; 50 patients did not receive antifungal treatment. Among the 271 patients, cavities closed in 38 (14.0%). Statistical modeling showed that cavities were more likely to close in patients in the treated group than in the nontreated group (hazard ratio, 2.14 [95% CI: 1.45–5.66]). Cavities were less likely to close in active smokers than nonsmokers (11/41 [26.8%] vs 97/182 [53.3%]; P = 0.002) or in persons with than without diabetes (27/74 [36.5%] vs 81/149 [54.4%]; P = 0.01).We did not find an association between cavity size and closure. Our findings provide rationale for further study of treatment protocols in this subset of patients with coccidioidomycosis. Lay Summary Coccidioidomycosis, known as valley fever, is a fungal infection that infrequently causes cavities to form in the lungs, which potentially results in long-term lung symptoms. We learned that cavities closed more often in persons who received antifungal drugs, but most cavities never closed completely.
Favorable Reoperation Rate at 2 Years Following Repair of Horizontal Cleavage Tears Using an All Suture‐Based Technique: A Prospective, Multicenter Trial
Kurzweil, Peter R. , Krych, Aaron J. , Anz, Adam W. , Gwathmey, F. Winston , Loren, Gregory J. , Lavery, Matthew Ryan , Flanigan, David C. , Krych, Aaron J , Lavery, Matthew

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | March 14, 2021 | Volume: 3 | Issue: 3 | Pages: No page available

10.1016/j.asmr.2021.01.018 | PMID 34195644 Get It

Purpose This prospective, multicenter trial evaluates the clinical success (as measured by reoperation rates and improvements in patient‐reported outcome measures) of using circumferential compression stitches with all‐suture techniques for horizontal cleavage tears (HCTs) of the meniscus. Methods Investigators enrolled 30 patients (mean age, 38.2 years; standard deviation, 11.1 years) aged 18 to 60 years with HCTs in the symptomatic compartment at 8 centers in the United States who underwent HCT repair with all‐suture circumferential stitches using a self‐retrieving all‐inside suture passing device. Postoperative follow‐up visits were conducted at 6 months, 1 year, and 2 years. Study outcomes included freedom from reoperation of the index meniscus repair site; knee pain and function, as measured by International Knee Documentation Committee Knee evaluation (IKDC), Knee injury and Osteoarthritis Outcome Score, Lysholm Knee Scale, and Tegner Activity Scale; and serious complications observed during the study. Minimal clinically important difference at 1 year was assessed for IKDC and Lysholm. Results Twenty‐three patients had 2‐year follow‐up data available. Freedom from reoperation was 96.0% at 6 months (26/27, 91.7% at 1 year [23/25], and 82.6% at 2 years [19/23]). Significant improvement was observed in over baseline at 2 years for IKDC (36.7‐82.5; P < .001), Knee injury and Osteoarthritis Outcome Score (52.2‐89.3; P < .001), Lysholm (50.2‐87.4; P < .001), and Tegner scores (3.3‐5.3; P = .007). Minimal clinically important difference was met or exceeded for IKDC and Lysholm scores at 1 year 69.2% and 65.4% of patients, respectively. Four patients (6.7%) experienced serious complications, of which 2 were assessed as being related to the procedure. Conclusions Repair of HCTs using all‐suture circumferential stitches placed with a self‐retrieving all‐inside suture passing device leads to a favorable reoperation rate (17.4%), significant improvements in clinical outcomes, and an acceptable rate of serious complications (6.7%) at 2 years, supporting the viability of this treatment approach in this indication. Level of Evidence Level IV, therapeutic case series.
Hemispherectomy Outcome Prediction Scale: Development and validation of a seizure freedom prediction tool
Weil, Alexander G. , Lewis, Evan , Ibrahim, George M. , Tseng, Chi‐Hong , Zhou, Xinkai , Lin, Kao‐Min, Cai, Lixin , Liu, Qingzhu , Lin, Jiuluan , Mathern, Gary W. , Smyth, Matthew D. , O’Neill, Brent R., Dudley, Roy , Ragheb, John , Bhatia, Sanjiv, Delev, Daniel , Ramantani, Georgia , Zentner, Josef , Dorfer, Christian , Feucht, Martha , Czech, Thomas , Bollo, Robert J. , Issabekov, Galymzhan , Zhu, Hongwei , Connelly, Mary Shane, Steinbok, Paul , Zhang, Kai , Hidalgo, Eveline Teresa , Weiner, Howard L. , Lapalme‐Remis, Samuel , Tripathi, Manjari , Chandra, P. Sarat , Hader, Walter , Wang, Feng‐Peng , Champagne, Pierre Olivier, Budke, Marcelo , Pérez-Jiménez, María Ángeles, Raftapoulos, Christian, Finet, Patrice, Michel, Pauline, Schaller, Karl , Malone, Christian Cantillano, Pociecha, Juan , Chamorro, Noelia, Muro, Valeria L., Lehe, Marec von , Vieker, Silvia, Oluigbo, Chima , Gaillard, William D. , Khateeb, Mashael Al, Alotaibi, Faisal , Krayenbühl, Niklaus , Bolton, Jeffrey , Ramantani, Georgia , Dorfer, Christian , Feucht, Martha , Wong-Kisiel, Lily, Tripathi, Manjari , Sarat Chandra, Poodipedi , Gaillard, William D , Fallah, Aria , von Lehe, Marec , Weil, Alexander G , Oluigbo, Chima O , Kola, Olivia , Zhou, Wen-Jing , Ojemann, Jeffrey G. , Wang, Anthony , Connelly, Mary, Zhang, Jianguo , Wong‐Kisiel, Lily C. , Wang, Feng‐Peng, Yao, Yi , Guo, Qiang , Li, Shao‐Chun, Stienen, Martin Nikolaus , Baro, Valentina , Pearl, Phillip L. , Fallah, Aria

Mayo Clinic

Epilepsia | March 13, 2021 | Volume: 62 | Issue: 5 | Pages: 1064-1073

10.1111/epi.16861 | PMID 33713438 Get It

AbstractObjectiveTo develop and validate a model to predict seizure freedom in children undergoing cerebral hemispheric surgery for the treatment of drug‐resistant epilepsy.MethodsWe analyzed 1267 hemispheric surgeries performed in pediatric participants across 32 centers and 12 countries to identify predictors of seizure freedom at 3 months after surgery. A multivariate logistic regression model was developed based on 70% of the dataset (training set) and validated on 30% of the dataset (validation set). Missing data were handled using multiple imputation techniques.ResultsOverall, 817 of 1237 (66%) hemispheric surgeries led to seizure freedom (median follow‐up = 24 months), and 1050 of 1237 (85%) were seizure‐free at 12 months after surgery. A simple regression model containing age at seizure onset, presence of generalized seizure semiology, presence of contralateral 18‐fluoro‐2‐deoxyglucose–positron emission tomography hypometabolism, etiologic substrate, and previous nonhemispheric resective surgery is predictive of seizure freedom (area under the curve = .72). A Hemispheric Surgery Outcome Prediction Scale (HOPS) score was devised that can be used to predict seizure freedom.SignificanceChildren most likely to benefit from hemispheric surgery can be selected and counseled through the implementation of a scale derived from a multiple regression model. Importantly, children who are unlikely to experience seizure control can be spared from the complications and deficits associated with this surgery. The HOPS score is likely to help physicians in clinical decision‐making.
Prognostic Impact of Acute Pulmonary Triggers in Patients with Takotsubo Syndrome: New Insights from the International Takotsubo Registry
Cammann, Victoria L. , Napp, L. Christian , Szawan, Konrad A. , Micek, Jozef, Dreiding, Sara, Levinson, Rena A. , Petkova, Vanya, Würdinger, Michael , Sumalinog, Rafael, Gili, Sebastiano , Clarenbach, Christian F. , Kohler, Malcolm , Wischnewsky, Manfred , Citro, Rodolfo , Vecchione, Carmine , Bossone, Eduardo , Franke, Jennifer , Meder, Benjamin , Knorr, Maike, Heiner, Susanne, Burgdorf, Christof , Kherad, Behrouz , Tschöpe, Carsten , Sarcon, Annahita, Shinbane, Jerold S., Rajan, Lawrence, Michels, Guido, Pfister, Roman , Cuneo, Alessandro , Jacobshagen, Claudius, Karakas, Mahir , Köenig, Wolfgang , Pott, Alexander , Meyer, Philippe , Roffi, Marco , Banning, Adrian , Wolfrum, Mathias , Cuculi, Florim , Fischer, Thomas, Vasankari, Tuija , Budnik, Monika , Dworakowski, Rafał , MacCarthy, Philip , Osswald, Stefan , Galiuto, Leonarda , Chan, Christina , Bridgman, Paul , Beug, Daniel , Gilyarova, Ekaterina, Gilyarov, Mikhail , El‐Battrawy, Ibrahim , Akın, İbrahim , Kozel, Martin , Winchester, David E. , Ukena, Christian , Carrilho‐Ferreira, Pedro , Hauck, Christian , Paolini, Carla , Bilato, Claudio , Sano, Masanori, Ishibashi, Iwao, Takahara, Masayuki, Himi, Toshiharu, Kobayashi, Yoshio , Prasad, Abhiram , Rihal, Charanjit S. , Liu, Kan , Bianco, Matteo , Jörg, Lucas, Rickli, Hans , Pestana, Gonçalo , Böhm, Michael , Maier, Lars S. , Pinto, Fausto J. , Widimský, Petr , Felix, Stephan B. , Opolski, Grzegorz , Rottbauer, Wolfgang , Pieske, Burkert , Borggrefe, Martin, Katus, Hugo A. , Münzel, Thomas , Crea, Filippo , Lüscher, Thomas F. , Ghadri, Jelena R. , Templin, Christian , Gilyarov, Mikhail , Bossone, Eduardo , Crea, Filippo , Citro, Rodolfo , El-Battrawy, Ibrahim , Prasad, Abhiram , Vecchione, Carmine , Tschöpe, Carsten , Koenig, Wolfgang , Meyer, Philippe , Banning, Adrian , Gilyarov, Mikhail , Ukena, Christian , Bilato, Claudio , Bianco, Matteo , Kato, Ken , Patrascu, Alexandru , Neuhaus, Michael, Jaguszewski, Miłosz , Noutsias, Michel , D’Ascenzo, Fabrizio , Dichtl, Wolfgang , Kobza, Richard , Airaksinen, Juhani , Kaiser, Christoph A. , Delmas, Clément , Lairez, Olivier , Shilova, Alexandra S. , Toušek, Petr , Gałuszka, Jan , Poglajen, Gregor , Rihal, Charanjit S. , Schulze, Paul Christian , Nguyen, Thanh Ha Tuan , Braun-Dullaeus, Ruediger Christian , Hasenfuß, Gerd , Schunkert, Heribert , Thiele, Hölger , Bauersachs, Johann , Horowitz, John D. , Mario, Carlo Di , Bax, Jeroen J. , Ruschitzka, Frank T.

Mayo Clinic

ESC Heart Failure | March 13, 2021 | Volume: 8 | Issue: 3 | Pages: 1924-1932

10.1002/ehf2.13165 | PMID 33713566 Get It

Abstract Aims Acute pulmonary disorders are known physical triggers of takotsubo syndrome (TTS). This study aimed to investigate prevalence of acute pulmonary triggers in patients with TTS and their impact on outcomes. Methods and results Patients with TTS were enrolled from the International Takotsubo Registry and screened for triggering factors and comorbidities. Patients were categorized into three groups (acute pulmonary trigger, chronic lung disease, and no lung disease) to compare clinical characteristics and outcomes. Of the 1670 included patients with TTS, 123 (7%) were identified with an acute pulmonary trigger, and 194 (12%) had a known history of chronic lung disease. The incidence of cardiogenic shock was highest in patients with an acute pulmonary trigger compared with those with chronic lung disease or without lung disease (17% vs. 10% vs. 9%, P = 0.017). In-hospital mortality was also higher in patients with an acute pulmonary trigger than in the other two groups, although not significantly (5.7% vs. 1.5% vs. 4.2%, P = 0.13). Survival analysis demonstrated that patients with an acute pulmonary trigger had the worst long-term outcome (P = 0.002). The presence of an acute pulmonary trigger was independently associated with worse long-term mortality (hazard ratio 2.12, 95% confidence interval 1.33–3.38; P = 0.002). Conclusions The present study demonstrates that TTS is related to acute pulmonary triggers in 7% of all TTS patients, which accounts for 21% of patients with physical triggers. The presence of acute pulmonary trigger is associated with a severe in-hospital course and a worse long-term outcome.
It is Time to Uncover the Mysterious veil of Atrioventricular Node Pacing
Ma, Chengming , Cha, Yong‐Mei , Dong, Yingxue , Gao, Lianjun , Xia, Yunlong , Dong, Yingxue

Mayo Clinic

No container title available | March 13, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.161565830.00191930/v1 Get It

Wenckebach phenomenon is a well-known electrophysiological character of the atrioventricular node (AVN). AVN-pacing during permanent pacemaker implantation is rare. We herein report the first case of Wenckebach phenomenon in a heart failure patient with chronic atrial fibrillation for more than 30 years during the His-bundle pacing (HBP) procedure. The patient’s symptoms improved significantly. AVN-pacing is available, and HBP is helpful for cardiac remodeling and clinical outcomes.
Pre-Operative Assessment of Patients Undergoing Spinal Cord Stimulation for Refractory Angina Pectoris
Langford, Brendan , Mauck, William D. , Hunt, Christine , Hunt, Christine , Lerman, Amir

Mayo Clinic

Pain Medicine | March 13, 2021 | Volume: 22 | Issue: 11 | Pages: 2763-2767

10.1093/pm/pnab105 | PMID 33734390 Get It

Abstract Spinal cord stimulation (SCS) is used to treat a variety of chronic pain conditions refractory to more conservative management including refractory angina pectoris. We identified 31 patients who underwent SCS implantation for the indication of refractory angina at a single institution from 2003 through 2018. Sixteen patients were male, and 15 were female. Average age was 53.9 years. Prior to SCS implantation, all patients had at least one coronary angiogram. Ten (32.3%) patients had undergone percutaneous coronary intervention, and four (12.9%) had undergone coronary artery bypass grafting. Thirty patients (96.7%) were currently using anti-angina medications. Twenty-six patients (83.9%) were on antiplatelet or anticoagulant agents at the time of SCS evaluation. Spinal cord stimulation implanters must perform a comprehensive evaluation incorporating appropriate multidisciplinary care particularly in patients with refractory angina given their cardiovascular comorbidities. It is important to have baseline data (e.g., pain scores, nitroglycerin consumption, frequency of angina episodes, and a questionnaire, such as the Seattle Angina Questionnaire) to compare with follow-up data to help define treatment success. We report a single institution’s pre-operative experience for patients undergoing SCS for refractory angina to illustrate unique pre-operative SCS considerations in this chronic pain population.
Differential characteristics and outcomes of Asian and non‐Asian patients with HBV‐related hepatocellular carcinoma
Huang, Daniel Q. , Hoang, Joseph , Leong, Jennifer , Maeda, Mayumi , Yang, Ju Dong , Accarino, Elena Vargas, Thin, Khin , Trinh, Lindsey , Cheung, Ramsey , Roberts, Lewis R. , Schwartz, Myron , Nguyen, Mindie H. , Riveiro-Barciela, Mar , Cheung, Ramsey C , Buti, Maria , Nguyen, Mindie H , Roberts, Lewis R , Huang, Daniel Q , Yang, Ju Dong , Buti, Marı́a

Mayo Clinic

Liver International | March 13, 2021 | Volume: 41 | Issue: 8 | Pages: 1922-1932

10.1111/liv.14877 | PMID 33713386 Get It

Abstract Background & Aims The epidemiology of hepatitis B virus (HBV) infection differs between Asians and non‐Asians, but little is known regarding the effect of ethnicity on outcomes of HBV‐related hepatocellular carcinoma (HCC). We aim to characterize the presentation and survival outcomes in Asian and non‐Asian patients with HBV‐related HCC. Methods We analyzed the baseline characteristics and long‐term survival of 613 Asian and 410 non‐Asian patients with HBV‐related HCC from three US and one Spanish centre. Results Overall, non‐Asian patients were more likely to have HIV or hepatitis C co‐infection, cirrhosis, decompensated liver disease and advanced BCLC stage (all P ≤ .04). Compared with Asians, non‐Asians were more likely to be listed for transplantation ( P < .0001) and undergo HCC treatment with curative intent ( P = .003). Propensity‐score matching on HCC diagnosis year, gender and age was performed to balance the two groups for survival analysis and yielded 370 pairs of patients. There was no significant difference in survival overall ( P = .43) and among patients with cirrhosis ( P = .57). Among patients without cirrhosis, non‐Asians had poorer 5‐year survival compared with Asians (37.6% vs 53.7%, P = .01), and was associated with poorer survival after adjusting for age, gender, diabetes, alcohol, co‐infections, diagnosis date, antiviral therapy, BCLC stage and HCC treatment (adjusted HR 2.01 [95% CI 1.07‐3.74], P = .03). Conclusion Among HBV‐related HCC patients, non‐Asians presented with more advanced BCLC stage compared to Asians. Non‐Asian ethnicity was independently associated with twice the risk of mortality among patients without cirrhosis, but not among those with cirrhosis. Additional studies are needed to clarify this disparity.
Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation
Bhanji, Rahima A. , Watt, Kymberly D.

Mayo Clinic

Liver Transplantation | March 13, 2021 | Volume: 27 | Issue: 7 | Pages: 1041-1053

10.1002/lt.26052 | PMID 33713382 Get It

Physiologic reserve is an important prognostic indicator. Because of its complexity, no single test can measure an individual’s physiologic reserve. Frailty is the phenotypic expression of decreased reserve and portends poor prognosis. Both subjective and objective tools have been used to measure one or more components of physiologic reserve. Most of these tools appear to predict pretransplant mortality, but only some predict posttransplant survival. Incorporation of these measures of physiologic reserve in the clinical and research settings including prediction models are reviewed, and the applicability to patient‐related outcomes are discussed. Commonly used tools, in patients with cirrhosis, that have been associated with clinical outcomes were reviewed. The strength of subjective tools lies in low‐cost, wide availability, and quick assessments at the bedside. A disadvantage of these tools is the manipulative capacity, restricting their value in allocation processes. The strength of objective tests lies in objective measurements and the ability to measure change. The disadvantages include complexity, increased cost, and limited accessibility. Heterogeneity in the definitions and tools used has prevented further advancement or a clear role in transplant assessment. Consistent use of objective tools, including the 6‐minute walk test, gait speed, Liver Frailty Index, or Short Physical Performance Battery, are recommended in clinical and research settings.